Podcasts

ASCP panel offers deprescribing guidance to curb psychiatric overprescribing, simplify polypharmacy, and improve outcomes with tapering and

In the first ever episode of "On Your Mind With Erin Crown," explore how tribalism hurts the field of psychiatry and ultimately patient outcomes.

David Dunner, MD, FACPsych, reveals insights into rapid cycling roots, bipolar II, and weighing lithium as an often overlooked treatment option.

Experts reveal why psych medication nonadherence is common, how to discuss it without blame, and tools like CAE and injectables to prevent relapse.

Experts unpack why most psychiatric care relies on off‑label meds, how neuroscience guides safe polypharmacy, and what could reshape FDA approvals.

In this inaugural episode, experts discuss the limitations of current diagnosis-based frameworks in suicide research, emphasizing the need for more targeted interventions.

Experts urge early bipolar disorder treatment, highlighting lithium’s underuse despite neuroprotective, antisuicidal benefits and evidence that delays worsen outcomes and responsiveness.

Experts explain how careful pediatric psychopharmacology and early intervention protect development, curb relapse, and address substance-use risk.

Explore psychopharmacologic options for personality disorders in this podcast.

Psychiatry leaders unpack pharmacogenetic testing hype, spotlight 4 actionable genes, and urge evidence-based use with therapeutic drug monitoring for personalized treatment.

Psilocybin therapy shows fast, lasting relief for depression; clinicians discuss trial hurdles and emerging promise for PTSD and addiction in this podcast.

Learn when CBT/IPT beats medications, when to combine antidepressants, and why patient preference drives depression recovery in 6–12 weeks in this podcast.

A psychiatrist and psychiatric nurse practitioner discuss collaboration and patient support.

Explore GLP-1 agonists and their "truly transformative" role in psychiatry in this podcast.

Learn more about the treatment of depression, selective serotonin reuptake inhibitors, and pregnancy in this podcast.

Dissect psychodermatology with experts in both fields, from the American Academy of Dermatology 2026.

Explore how depression, anxiety, diet, and social factors shape heart disease—and why cardiology and psychiatry must team up for better care.

Experts unpack bereavement’s hidden health and economic toll.

Explore how Shambrekia Wise's "Sightseeing with Sandy" series promotes cultural humility and empathy in children through global travel and shared experiences.

Explore the transformative power of vulnerability in mental health and human connection with insights from Manizeh Mirza-Gruber, MD, and Frank Clark, MD.

In this podcast, Psychiatric Times editor-in-chief Dr. John J. Miller interviews Dr. Stephen Faraone, distinguished professor and vice chair of research of psychiatry and behavioral sciences at Upstate Medical University in Syracuse, New York, about the evolving world of nonpharmacologic interventions for ADHD, in particular digital therapeutics.

Research is underway to make psychedelics agents a treatment option for psychiatric disorders.

Scare tactics don’t work. But scientific education might. Here are tips for talking with teenaged patients about keeping themselves and their friends safe.

How to regulate circadian rhythms and regulate mood using dark therapy.

Forensic psychiatry is not for everyone, but looking back on his life and illustrious career, James L. Knoll IV, MD, realizes that he was destined to study crime.

James L. Knoll IV, MD, shares insights from his decades in forensic psychiatry, where he has treated some of the criminal justice system’s most difficult and dangerous patients.

What can Olympians teach mental health professionals about caring for student athletes—and others too?

Blue light is associated with a host of physical health maladies, including obesity, diabetes, and cancer. But what does it do to patients with depression or bipolar disorder?

A deep dive into the history, side effects, and efficacy of a controversial drug.